Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein. - Patterson JR; Hirst WD; Howe JW; Russell CP; Cole-Strauss A; Kemp CJ; Duffy MF; Lamp J; Umstead A; Kubik M; Stoll AC; Vega IE; et al. (NPJ Parkinson's disease, 2022)